Dynamic Extracellular Matrix Remodeling and Immune Reprogramming in the Postpartum Mammary Gland: Implications for Maternal Health and Breast Cancer Risk

Document Type : Scientific Review

Authors

1 Mother and Newborn Health Research Center, Comprehensive Research Institute for Maternal and Child Health, Shahid Sadoughi University of Medical Sciences, Yazd, Iran

2 Monoclonal Antibody Research Center, Avicenna Research Institute, ACECR, Tehran, Iran

Abstract

The mammary gland is a uniquely dynamic organ, undergoing profound structural and functional transformations throughout the pregnancy-lactation-involution cycle. These changes are orchestrated by a complex interplay between systemic hormones and the local microenvironment.
Recent studies identify the extracellular matrix (ECM) and the innate immune landscape as critical determinants of both physiological tissue homeostasis and pathological progression. Postpartum breast cancer (PPBC), defined as breast cancer diagnosed within ten years following childbirth, represents a distinct clinical entity characterized by increased
aggressiveness, higher metastatic potential, and poor prognosis. This review provides a comprehensive synthesis of recent updates in mammary gland biology, focusing on the triphasic pattern of collagen regulation, the role of matrix metalloproteinases (MMPs) and lysyl oxidase (LOX) in tissue remodeling, and the emergence of an immunosuppressive "wound-healing" environment during involution.
We explore molecular regulatory nodes, including microRNAs and calpains, and the impact of environmental exposures on breast tissue composition. By integrating data derived from high-resolution spatial profiling and single-cell transcriptomic analyses, this article aims to provide an understanding of how the postpartum mammary microenvironment supports tumorigenesis, highlighting potential biomarkers and therapeutic targets to improve maternal health outcomes.

Keywords

References

1. Bray F, Laversanne M, Sung H, Ferlay J, Siegel RL, Soerjomataram I, et al. Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 2024; 74(3): 229-63.
2. Nichols HB, Schoemaker MJ, Cai J, Xu J, Wright LB, Brook MN, et al. Breast Cancer Risk After Recent Childbirth: A Pooled Analysis of 15 Prospective Studies. Ann Intern Med 2019; 170(1): 22-30.
3. Mathews TJ, Hamilton BE. Mean Age of Mothers is on the Rise: United States, 2000-2014. NCHS Data Brief 2016 (232): 1-8.
4. Jindal S, Pennock ND, Sun D, Horton W, Ozaki MK, Narasimhan J, et al. Postpartum breast cancer has a distinct molecular profile that predicts poor outcomes. Nat Commun 2021; 12(1): 6341.
5. Nimbalkar VP, Snijesh VP, Rajarajan S, Alexander A, Kaluve R, Ramesh R, et al. Premenopausal women with breast cancer in the early post-partum period show molecular profiles of invasion and are associated with poor prognosis. Breast Cancer Res Treat 2023; 200(1): 139-49.
6. Fornetti J, Martinson HA, Betts CB, Lyons TR, Jindal S, Guo Q, et al. Mammary gland involution as an immunotherapeutic target for postpartum breast cancer. J Mammary Gland Biol Neoplasia 2014; 19(2): 213-28.
7. Watson CJ, Khaled WT. Mammary development in the embryo and adult: new insights into the journey of morphogenesis and commitment. Development 2020; 147(22): dev169862.
8. Jindal S, Narasimhan J, Borges VF, Schedin P. Characterization of weaning-induced breast involution in women: implications for young women's breast cancer. NPJ Breast Cancer 2020; 6: 55.
9. O'Brien J, Lyons T, Monks J, Lucia MS, Wilson RS, Hines L, et al. Alternatively activated macrophages and collagen remodeling characterize the postpartum involuting mammary gland across species. Am J Pathol 2010; 176(3): 1241-55.
10. Sherman ME, Etievant L, Vierkant RA, Winham SJ, Ruddy KJ, Pacheco-Spann L, et al. Postpartum breast cancer: evidence for a distinct phenotype. J Natl Cancer Inst 2026; 118(5): 926-36.
11. Valdés-Mora F, Salomon R, Gloss BS, Law AMK, Venhuizen J, Castillo L, et al. Single-cell transcriptomics reveals involution mimicry during the specification of the basal breast cancer subtype. Cell Rep 2021; 35(2): 108945.
12. Arendt LM, Kuperwasser C. Form and function: how estrogen and progesterone regulate the mammary epithelial hierarchy. J Mammary Gland Biol Neoplasia 2015; 20(1-2): 9-25.
13. Macias H, Hinck L. Mammary gland development. Wiley Interdiscip Rev Dev Biol 2012; 1(4): 533-57.
14. Yamaguchi K, Nakayama J, Yamamoto T, Semba K, Shirota T, Yamamoto Y. Collagen induction of immune cells in the mammary glands during pregnancy. Physiol Genomics 2024; 56(2): 128-35.
15. Guo Q, Sun D, Barrett AS, Jindal S, Pennock ND, Conklin MW, et al. Mammary collagen is under reproductive control with implications for breast cancer. Matrix Biol 2022; 105: 104-26.
16. Melcher ML, Block I, Kropf K, Singh AK, Posern G. Interplay of the transcription factor MRTF-A and matrix stiffness controls mammary acinar structure and protrusion formation. Cell Commun Signal 2022; 20(1): 158.
17. Warburton MJ, Mitchell D, Ormerod EJ, Rudland P. Distribution of myoepithelial cells and basement membrane proteins in the resting, pregnant, lactating, and involuting rat mammary gland. J Histochem Cytochem 1982; 30(7): 667-76.
18. Zwick RK, Rudolph MC, Shook BA, Holtrup B, Roth E, Lei V, et al. Adipocyte hypertrophy and lipid dynamics underlie mammary gland remodeling after lactation. Nat Commun 2018; 9(1): 3592.
19. Stein T, Salomonis N, Gusterson BA. Mammary gland involution as a multi-step process. J Mammary Gland Biol Neoplasia. 2007; 12(1): 25-35.
20. Baxter FO, Neoh K, Tevendale MC. The beginning of the end: death signaling in early involution. J Mammary Gland Biol Neoplasia 2007; 12(1): 3-13.
21. Hughes K, Watson CJ. The Multifaceted Role of STAT3 in Mammary Gland Involution and Breast Cancer. Int J Mol Sci 2018; 19(6): 1695.
22. Mironov A, Fisher M, Narayanan P, Elsayed R, Karabulutoglu M, Akhtar N. Rac1 controls cell turnover and reversibility of the involution process in postpartum mammary glands. PLoS Biol 2023; 21(1): e3001583.
23. Werb Z, Ashkenas J, MacAuley A, Wiesen JF. Extracellular matrix remodeling as a regulator of stromal-epithelial interactions during mammary gland development, involution and carcinogenesis. Braz J Med Biol Res 1996;
29(9): 1087-97.
24. Hanayama R, Nagata S. Impaired involution of mammary glands in the absence of milk fat globule EGF factor 8. Proc Natl Acad Sci U S A 2005; 102(46): 16886-91.
25. Lefrère H, Floris G, Schmidt MK, Neven P, Warner E, Cardonick E, et al. Breast cancer diagnosed in the post-weaning period is indicative for a poor outcome. Eur J Cancer 2021; 155: 13-24.
26. Lefrère H, Lenaerts L, Borges VF, Schedin P, Neven P, Amant F. Postpartum breast cancer: mechanisms underlying its worse prognosis, treatment implications, and fertility preservation. Int J Gynecol Cancer 2021; 31(3): 412-22.
27. Callihan EB, Gao D, Jindal S, Lyons TR, Manthey E, Edgerton S, et al. Postpartum diagnosis demonstrates a high risk for metastasis and merits an expanded definition of pregnancy-associated breast cancer. Breast Cancer Res Treat 2013; 138(2): 549-59.
28. Goddard ET, Hill RC, Nemkov T, D'Alessandro A, Hansen KC, Maller O, et al. The Rodent Liver Undergoes Weaning-Induced Involution and Supports Breast Cancer Metastasis. Cancer Discov 2017; 7(2): 177-87.
29. Joyce JA, Fearon DT. T cell exclusion, immune privilege, and the tumor microenvironment. Science 2015; 348(6230): 74-80.
30. Hitchcock J, Hughes K, Pensa S, Lloyd-Lewis B, Watson CJ. The immune environment of the mammary gland fluctuates during postlactational regression and correlates with tumour growth rate. Development 2022; 149(8): dev200162.
31. Yu J, Yan Y, Li S, Xu Y, Parolia A, Rizvi S, et al. Progestogen-driven B7-H4 contributes to onco-fetal immune tolerance. Cell 2024; 187(17): 4713-32.e19.
32. Levental KR, Yu H, Kass L, Lakins JN, Egeblad M, Erler JT, et al. Matrix crosslinking forces tumor progression by enhancing integrin signaling. Cell 2009; 139(5): 891-906.
33. O'Brien JH, Vanderlinden LA, Schedin PJ, Hansen KC. Rat mammary extracellular matrix composition and response to ibuprofen treatment during postpartum involution by differential GeLC-MS/MS analysis. J Proteome Res 2012; 11(10): 4894-905.
34. McDaniel SM, Rumer KK, Biroc SL, Metz RP, Singh M, Porter W, et al. Remodeling of the mammary microenvironment after lactation promotes breast tumor cell metastasis. Am J Pathol 2006; 168(2): 608-20.
35. Lyons TR, O'Brien J, Borges VF, Conklin MW, Keely PJ, Eliceiri KW, et al. Postpartum mammary gland involution drives progression of ductal carcinoma in situ through collagen and COX-2. Nat Med 2011; 17(9): 1109-15.
36. Parés S, Cano-Garrido O, Bach A, Ferrer-Miralles N, Villaverde A, Garcia-Fruitós E, et al. The Potential of Metalloproteinase-9 Administration to Accelerate Mammary Involution and Boost the Immune System at Dry-Off. Animals (Basel) 2021; 11(12): 3415.
37. Doyle M, Kwami N, Joshi J, Arendt LM, McCready J. Interaction between Macrophages and Adipose Stromal Cells Increases the Angiogenic and Proliferative Potential of Pregnancy-Associated Breast Cancers. Cancers (Basel) 2023; 15(18): 4500.
38. Martinson HA, Jindal S, Durand-Rougely C, Borges VF, Schedin P. Wound healing-like immune program facilitates postpartum mammary gland involution and tumor progression. Int J Cancer 2015; 136(8): 1803-13.
39. Hicks SD, Chandran D, Confair A, Ward A, Kelleher SL. Human Milk-Derived Levels of let-7g-5p May Serve as a Diagnostic and Prognostic Marker of Low Milk Supply in Breastfeeding Women. Nutrients 2023; 15(3): 567.
40. Puebla S, Gimeno A, Ortíz-Zapater E, Zaragozá R, Viña JR, García-Trevijano ER. The Length of Lactation and Model of Weaning Modulate Key Regulatory Nodes of Murine Mammary Gland Involution. Int J Mol Sci 2025; 26(21): 10501.
41. Llobet-Navas D, Rodríguez-Barrueco R, Castro V, Ugalde AP, Sumazin P, Jacob-Sendler D, et al. The miR 424(322)/503 cluster orchestrates remodeling of the epithelium in the involuting mammary gland. Genes Dev 2014; 28(7): 765-82.
42. Spike AJ, Rosen JM. C/EBPß Isoform SpecificGene Regulation: It's a Lot more Complicated than you Think! J Mammary Gland Biol Neoplasia 2020; 25(1): 1-12.
43. Arnal-Estapé A, Tarragona M, Morales M, Guiu M, Nadal C, Massagué J, et al. HER2 silences tumor suppression in breast cancer cells by switching expression of C/EBPß isoforms. Cancer Res 2010; 70(23): 9927-36.
44. Sterken BA, Ackermann T, Müller C, Zuidhof HR, Kortman G, Hernandez-Segura A, et al.C/EBPβ isoform-specific regulation of migration and invasion in triple-negative breast cancer cells. NPJ Breast Cancer 2022; 8(1): 11.
45. Tovar-Parra D, McDermott A, Cardot J, Juarez MN, Joao F, El Omri-Charai R, et al. An in utero exposure to the synthetic estrogen diethylstilbestrol affects the fat pad composition in post-natal mammary glands. Toxicol Sci. 2026;209(1).
46. Ruiz TFR, Colleta SJ, Leonel ECR, Taboga SR. Mammary carcinoma in aged gerbil mothers after endocrine disruption in pregnancy and lactation. Endocr Relat Cancer 2021; 28(11): 715-30.
47. Kehm RD, Walter EJ, Oskar S, White ML, Tehranifar P, Herbstman JB, et al. Exposure to polycyclic aromatic hydrocarbons during pregnancy and breast tissue composition in adolescent daughters and their mothers: a prospective cohort study. Breast Cancer Res. 2022; 24(1): 47.
World Journal of Peri & Neonatology
Volume 8, Issue 1
May 2026
Pages 13-25

Files

History

  • Receive Date: 25 May 2026
  • Accept Date: 25 May 2026

Share

How to cite

Statistics